Developing Drugs as an academic means that you have to find many investors initially to help you move drugs along.
Big Pharma don't have too much interest in early stage compounds as they want to know if it works before taking the plunge.
However, its the company accountants that call the shots.
CoI We are founders of a company developing a treatment for MS
Labels: Advent Calendar